113 related articles for article (PubMed ID: 35679681)
21. Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway.
Kong C; Zhu Z; Li Y; Xue P; Chen L
Clin Transl Oncol; 2021 Jul; 23(7):1334-1341. PubMed ID: 33515421
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway.
Hu X; Han T; Bian Y; Tong H; Wen X; Li Y; Wan X
Oncol Rep; 2020 Mar; 43(3):919-929. PubMed ID: 32020231
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of B3GNT3 is associated with immune infiltration and activation of NF-κB pathway in gynecologic cancers.
Xu J; Guo Z; Yuan S; Li H; Luo S
J Reprod Immunol; 2022 Aug; 152():103658. PubMed ID: 35777165
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
[TBL] [Abstract][Full Text] [Related]
26. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
27. PRMT6 promotes endometrial cancer via AKT/mTOR signaling and indicates poor prognosis.
Jiang N; Li QL; Pan W; Li J; Zhang MF; Cao T; Su SG; Shen H
Int J Biochem Cell Biol; 2020 Mar; 120():105681. PubMed ID: 31884111
[TBL] [Abstract][Full Text] [Related]
28. Clinical prognostic significance and pro-metastatic activity of RANK/RANKL via the AKT pathway in endometrial cancer.
Wang J; Liu Y; Wang L; Sun X; Wang Y
Oncotarget; 2016 Feb; 7(5):5564-75. PubMed ID: 26734994
[TBL] [Abstract][Full Text] [Related]
29. IL-24 inhibits endometrial cancer cell proliferation by promoting apoptosis through the mitochondrial intrinsic signaling pathway.
Liao S; Yang Y; Chen S; Bi Y; Huang Q; Wei Z; Qin A; Liu B
Biomed Pharmacother; 2020 Apr; 124():109831. PubMed ID: 31972354
[TBL] [Abstract][Full Text] [Related]
30. Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway.
Zhou K; Zhao J; Qi L; He Y; Xu J; Dai M
Technol Cancer Res Treat; 2020; 19():1533033820964217. PubMed ID: 33034273
[TBL] [Abstract][Full Text] [Related]
31. Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer.
Kato M; Onoyama I; Yoshida S; Cui L; Kawamura K; Kodama K; Hori E; Matsumura Y; Yagi H; Asanoma K; Yahata H; Itakura A; Takeda S; Kato K
Int J Cancer; 2020 Oct; 147(7):1987-1999. PubMed ID: 32159851
[TBL] [Abstract][Full Text] [Related]
32. Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway.
Dong L; Du M; Lv Q
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):753-760. PubMed ID: 31168597
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of protein phosphatase 1 regulatory inhibitor subunit 14B, a molecule related to tumorigenesis, poor prognosis, and immune cell infiltration in lung adenocarcinoma.
Zheng YX; Shi S; Jiang XH; Liu KC; Qin ZJ; Wang YY; Li ZH; Chen MW
Am J Transl Res; 2023; 15(2):858-877. PubMed ID: 36915775
[TBL] [Abstract][Full Text] [Related]
34. Heat Shock Protein B7 Inhibits the Progression of Endometrial Carcinoma by Inhibiting PI3K/AKT/mTOR Pathway.
Xing M; Wu B; Wang S
Reprod Sci; 2023 Feb; 30(2):590-600. PubMed ID: 35859224
[TBL] [Abstract][Full Text] [Related]
35. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
[TBL] [Abstract][Full Text] [Related]
36. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation.
Sun NK; Huang SL; Chang TC; Chao CC
J Cell Biochem; 2013 Aug; 114(8):1819-31. PubMed ID: 23463670
[TBL] [Abstract][Full Text] [Related]
37. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
Wang Y; Yin L; Sun X
J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
[TBL] [Abstract][Full Text] [Related]
38. NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling.
Zhang Y; Goodfellow R; Li Y; Yang S; Winters CJ; Thiel KW; Leslie KK; Yang B
Gynecol Oncol; 2015 Oct; 139(1):127-33. PubMed ID: 26193427
[TBL] [Abstract][Full Text] [Related]
39. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.
Gagnon V; St-Germain ME; Parent S; Asselin E
Int J Oncol; 2003 Sep; 23(3):803-10. PubMed ID: 12888921
[TBL] [Abstract][Full Text] [Related]
40. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
